{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T04:34:56Z","timestamp":1792902896431,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Malaria results in over 600,000 deaths annually, with the highest burden of deaths in young children living in sub-Saharan Africa. Molecular surveillance can provide important information for malaria control policies, including detection of antimalarial drug resistance. However, genome sequencing capacity in malaria-endemic countries is limited. We designed and implemented an end-to-end workflow to detect\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    antimalarial resistance markers and diversity in the vaccine target\n                    <jats:italic>circumsporozoite protein<\/jats:italic>\n                    (\n                    <jats:italic>csp<\/jats:italic>\n                    ) using nanopore sequencing in Ghana. We analysed 196 clinical samples and showed that our method is rapid, robust, accurate and straightforward to implement. Importantly, our method could be applied to dried blood spot samples, which are readily collected in endemic settings. We report that\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    parasites in Ghana are mostly susceptible to chloroquine, with persistent sulfadoxine-pyrimethamine resistance and no evidence of artemisinin resistance. Multiple single nucleotide polymorphisms were identified in\n                    <jats:italic>csp<\/jats:italic>\n                    , but their significance is uncertain. Our study demonstrates the feasibility of nanopore sequencing for malaria genomic surveillance in endemic countries.\n                  <\/jats:p>","DOI":"10.1038\/s41564-023-01516-6","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T12:03:39Z","timestamp":1700741019000},"page":"2365-2377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana"],"prefix":"10.1038","volume":"8","author":[{"given":"Sophia T.","family":"Girgis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-9515","authenticated-orcid":false,"given":"Edem","family":"Adika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix E.","family":"Nenyewodey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dodzi K.","family":"Senoo Jnr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1698-609X","authenticated-orcid":false,"given":"Joyce M.","family":"Ngoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kukua","family":"Bandoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus","family":"van de Steeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7050-7996","authenticated-orcid":false,"given":"Alexandria J. R.","family":"Harrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Nsoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1811-428X","authenticated-orcid":false,"given":"Kim","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7386-3566","authenticated-orcid":false,"given":"Richard D.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0595-7333","authenticated-orcid":false,"given":"Jacob","family":"Almagro-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samirah","family":"Saiid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Atampah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6035-9220","authenticated-orcid":false,"given":"Enock K.","family":"Amoako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6988-150X","authenticated-orcid":false,"given":"Collins M.","family":"Morang\u2019a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Asoala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elrmion S.","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Burden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Roberts-Sengier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9887-6961","authenticated-orcid":false,"given":"Eleanor","family":"Drury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4867-5754","authenticated-orcid":false,"given":"Megan L.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f3nia","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8793-3641","authenticated-orcid":false,"given":"Gordon A.","family":"Awandare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic P.","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4468-0506","authenticated-orcid":false,"given":"Lucas N.","family":"Amenga-Etego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3330-353X","authenticated-orcid":false,"given":"William L.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"1516_CR1","unstructured":"World Malaria Report 2022 (WHO, 2022)."},{"key":"1516_CR2","unstructured":"Strategy to Respond to Antimalarial Drug Resistance in Africa (WHO, 2022)."},{"key":"1516_CR3","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","volume":"19","author":"RW van der Pluijm","year":"2019","unstructured":"van der Pluijm, R. W. et al. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study. Lancet Infect. Dis. 19, 952\u2013961 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"1516_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp, A. M. et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455\u2013467 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1516_CR5","doi-asserted-by":"publisher","unstructured":"Phyo A. P. et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(12)60484-X (2012).","DOI":"10.1016\/S0140-6736(12)60484-X"},{"key":"1516_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ng.2624","volume":"45","author":"O Miotto","year":"2013","unstructured":"Miotto, O. et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat. Genet. 45, 648\u2013655 (2013).","journal-title":"Nat. Genet."},{"key":"1516_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/infdis\/jiu491","volume":"211","author":"S Takala-Harrison","year":"2015","unstructured":"Takala-Harrison, S. et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J. Infect. Dis. 211, 670\u2013679 (2015).","journal-title":"J. Infect. Dis."},{"key":"1516_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng.3189","volume":"47","author":"O Miotto","year":"2015","unstructured":"Miotto, O. et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat. Genet. 47, 226\u2013234 (2015).","journal-title":"Nat. Genet."},{"key":"1516_CR9","doi-asserted-by":"publisher","unstructured":"Amato, R. et al. Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(18)30068-9 (2018).","DOI":"10.1016\/S1473-3099(18)30068-9"},{"key":"1516_CR10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","volume":"19","author":"WL Hamilton","year":"2019","unstructured":"Hamilton, W. L. et al. Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study. Lancet Infect. Dis. 19, 943\u2013951 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"1516_CR11","doi-asserted-by":"publisher","first-page":"e62997","DOI":"10.7554\/eLife.62997","volume":"10","author":"CG Jacob","year":"2021","unstructured":"Jacob, C. G. et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. Elife 10, e62997 (2021).","journal-title":"Elife"},{"key":"1516_CR12","doi-asserted-by":"publisher","unstructured":"Wasakul, V. et al. Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(22)00697-1 (2022).","DOI":"10.1016\/S1473-3099(22)00697-1"},{"key":"1516_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey, F. et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505, 50\u201355 (2014).","journal-title":"Nature"},{"key":"1516_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer, J. et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science 347, 428\u2013431 (2015).","journal-title":"Science"},{"key":"1516_CR15","doi-asserted-by":"publisher","first-page":"e66277","DOI":"10.7554\/eLife.66277","volume":"10","author":"BH Stokes","year":"2021","unstructured":"Stokes, B. H. et al. Plasmodium falciparum k13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness. Elife 10, e66277 (2021).","journal-title":"Elife"},{"key":"1516_CR16","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana, A. et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat. Med. 26, 1602\u20131608 (2020).","journal-title":"Nat. Med."},{"key":"1516_CR17","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana, A. et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect. Dis. 21, 1120\u20131128 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1516_CR18","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/infdis\/jiab352","volume":"225","author":"J Straimer","year":"2022","unstructured":"Straimer, J., Gandhi, P., Renner, K. C. & Schmitt, E. K. High prevalence of Plasmodium falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine. J. Infect. Dis. 225, 1411\u20131414 (2022).","journal-title":"J. Infect. Dis."},{"key":"1516_CR19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala, B. et al. Evidence of artemisinin-resistant malaria in Africa. N. Engl. J. Med. 385, 1163\u20131171 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1516_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","volume":"223","author":"V Asua","year":"2021","unstructured":"Asua, V. et al. Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda. J. Infect. Dis. 223, 985\u2013994 (2021).","journal-title":"J. Infect. Dis."},{"key":"1516_CR21","doi-asserted-by":"publisher","unstructured":"Beshir, K. B. et al. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine\u2013pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(22)00593-X (2022).","DOI":"10.1016\/S1473-3099(22)00593-X"},{"key":"1516_CR22","doi-asserted-by":"publisher","unstructured":"Amenga-Etego, L. N. et al. Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana. Malar J. https:\/\/doi.org\/10.1186\/s12936-021-03693-3 (2021).","DOI":"10.1186\/s12936-021-03693-3"},{"key":"1516_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1128\/AAC.00498-09","volume":"54","author":"C Karema","year":"2010","unstructured":"Karema, C. et al. Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria. Antimicrob. Agents Chemother. 54, 477\u2013483 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1516_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1086\/518512","volume":"196","author":"O Ma\u00efga","year":"2007","unstructured":"Ma\u00efga, O. et al. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J. Infect. Dis. 196, 165\u2013172 (2007).","journal-title":"J. Infect. Dis."},{"key":"1516_CR25","doi-asserted-by":"publisher","unstructured":"Naidoo, I. & Roper, C. Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria. Trends Parasitol. https:\/\/doi.org\/10.1016\/j.pt.2013.08.002 (2013).","DOI":"10.1016\/j.pt.2013.08.002"},{"key":"1516_CR26","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(20)32227-3","volume":"396","author":"E Baba","year":"2020","unstructured":"Baba, E. et al. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet 396, 1829\u20131840 (2020).","journal-title":"Lancet"},{"key":"1516_CR27","doi-asserted-by":"publisher","unstructured":"MalariaGEN et al. An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples [version 1; peer review: 2 approved]. Wellcome Open Res. https:\/\/doi.org\/10.12688\/wellcomeopenres.16168.1 (2021).","DOI":"10.12688\/wellcomeopenres.16168.1"},{"key":"1516_CR28","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/infdis\/jit618","volume":"209","author":"DC Nwakanma","year":"2014","unstructured":"Nwakanma, D. C. et al. Changes in malaria parasite drug resistance in an endemic population over a 25-year period with resulting genomic evidence of selection. J. Infect. Dis. 209, 1126\u20131135 (2014).","journal-title":"J. Infect. Dis."},{"key":"1516_CR29","first-page":"e01067","volume":"63","author":"K Wamea","year":"2019","unstructured":"Wamea, K. et al. No evidence of Plasmodium falciparum k13 artemisinin resistance-conferring mutations over a 24-year analysis in coastal Kenya but a near complete reversion to chloroquine-sensitive parasites. Antimicrob. Agents Chemother. 63, e01067-19 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1516_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.12688\/wellcomeopenres.17656.1","volume":"7","author":"I Omedo","year":"2022","unstructured":"Omedo, I. et al. Spatio-temporal distribution of antimalarial drug resistant gene mutations in a Plasmodium falciparum parasite population from Kilifi, Kenya: a 25-year retrospective study. Wellcome Open Res. 7, 45 (2022).","journal-title":"Wellcome Open Res."},{"key":"1516_CR31","doi-asserted-by":"publisher","unstructured":"Verity, R. et al. The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-020-15779-8 (2020).","DOI":"10.1038\/s41467-020-15779-8"},{"key":"1516_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1475-2875-11-223","volume":"11","author":"VA Mobegi","year":"2012","unstructured":"Mobegi, V. A. et al. Population genetic structure of Plasmodium falciparum across a region of diverse endemicity in West Africa. Malar. J. 11, 223 (2012).","journal-title":"Malar. J."},{"key":"1516_CR33","doi-asserted-by":"publisher","first-page":"e1007065","DOI":"10.1371\/journal.pgen.1007065","volume":"13","author":"AR Taylor","year":"2017","unstructured":"Taylor, A. R. et al. Quantifying connectivity between local Plasmodium falciparum malaria parasite populations using identity by descent. PLoS Genet. 13, e1007065 (2017).","journal-title":"PLoS Genet."},{"key":"1516_CR34","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/gbe\/evx126","volume":"9","author":"CM Parobek","year":"2017","unstructured":"Parobek, C. M. et al. Partner-drug resistance and population substructuring of artemisinin-resistant Plasmodium falciparum in Cambodia. Genome Biol. Evol. 9, 1673\u20131686 (2017).","journal-title":"Genome Biol. Evol."},{"key":"1516_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.aav5427","volume":"365","author":"A Amambua-Ngwa","year":"2019","unstructured":"Amambua-Ngwa, A. et al. Major subpopulations of Plasmodium falciparum in sub-Saharan Africa. Science 365, 813\u2013816 (2019).","journal-title":"Science"},{"key":"1516_CR36","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1086\/646613","volume":"200","author":"CV Plowe","year":"2009","unstructured":"Plowe, C. V., Alonso, P. & Hoffman, S. L. The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. J. Infect. Dis. 200, 1646\u20131649 (2009).","journal-title":"J. Infect. Dis."},{"key":"1516_CR37","unstructured":"World Malaria Report 2021 (WHO, 2021)."},{"key":"1516_CR38","doi-asserted-by":"publisher","unstructured":"Laurens, M. B. RTS,S\/AS01 vaccine (MosquirixTM): an overview. Hum. Vaccin. Immunother. https:\/\/doi.org\/10.1080\/21645515.2019.1669415 (2019).","DOI":"10.1080\/21645515.2019.1669415"},{"key":"1516_CR39","doi-asserted-by":"publisher","unstructured":"RTSS Clinical Trials Partnership. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(15)60721-8 (2015).","DOI":"10.1016\/S0140-6736(15)60721-8"},{"key":"1516_CR40","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","volume":"397","author":"MS Datoo","year":"2021","unstructured":"Datoo, M. S. et al. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. Lancet 397, 1809\u20131818 (2021).","journal-title":"Lancet"},{"key":"1516_CR41","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S1473-3099(22)00442-X","volume":"22","author":"MS Datoo","year":"2022","unstructured":"Datoo, M. S. et al. Efficacy and immunogenicity of R21\/Matrix-M vaccine against clinical malaria after 2 years\u2019 follow-up in children in Burkina Faso: a phase 1\/2b randomised controlled trial. Lancet Infect. Dis. 22, 1728\u20131736 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"1516_CR42","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa2034031","volume":"385","author":"MR Gaudinski","year":"2021","unstructured":"Gaudinski, M. R. et al. A monoclonal antibody for malaria prevention. N. Engl. J. Med. 385, 803\u2013814 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1516_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJMoa2203067","volume":"387","author":"RL Wu","year":"2022","unstructured":"Wu, R. L. et al. Low-dose subcutaneous or intravenous monoclonal antibody to prevent malaria. N. Engl. J. Med. 387, 397\u2013407 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1516_CR44","doi-asserted-by":"crossref","unstructured":"Kayentao, K. et al. Safety and efficacy of a monoclonal antibody against malaria in Mali. N. Engl. J. Med. 387, 1833\u20131842 (2022).","DOI":"10.1056\/NEJMoa2206966"},{"key":"1516_CR45","unstructured":"Accelerating Access to Genomics for Global Health: Promotion, Implementation, Collaboration, and Ethical, Legal, and Social Issues. A Report of the WHO Science Council (WHO, 2022)."},{"key":"1516_CR46","doi-asserted-by":"publisher","first-page":"757844","DOI":"10.3389\/fcimb.2022.757844","volume":"12","author":"BM Lyimo","year":"2022","unstructured":"Lyimo, B. M. et al. Potential opportunities and challenges of deploying next generation sequencing and CRISPR-Cas systems to support diagnostics and surveillance towards malaria control and elimination in Africa. Front. Cell. Infect. Microbiol. 12, 757844 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1516_CR47","doi-asserted-by":"publisher","unstructured":"Inzaule, S. C., Tessema, S. K., Kebede, Y., Ogwell, Ouma A. E. & Nkengasong, J. N. Genomic-informed pathogen surveillance in Africa: opportunities and challenges. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(20)30939-7 (2021).","DOI":"10.1016\/S1473-3099(20)30939-7"},{"key":"1516_CR48","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S1473-3099(20)30562-4","volume":"20","author":"LW Meredith","year":"2020","unstructured":"Meredith, L. W. et al. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study. Lancet Infect. Dis. 20, 1263\u20131271 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"1516_CR49","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S1473-3099(21)00251-6","volume":"21","author":"WL Hamilton","year":"2021","unstructured":"Hamilton, W. L. et al. Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19. Lancet Infect. Dis. 21, 916\u2013917 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1516_CR50","doi-asserted-by":"publisher","first-page":"msac025","DOI":"10.1093\/molbev\/msac025","volume":"39","author":"CJR Illingworth","year":"2022","unstructured":"Illingworth, C. J. R. et al. A2B-COVID: a tool for rapidly evaluating potential SARS-CoV-2 transmission events. Mol. Biol. Evol. 39, msac025 (2022).","journal-title":"Mol. Biol. Evol."},{"key":"1516_CR51","doi-asserted-by":"publisher","first-page":"eabq5358","DOI":"10.1126\/science.abq5358","volume":"378","author":"H Tegally","year":"2022","unstructured":"Tegally, H. et al. The evolving SARS-CoV-2 epidemic in Africa: insights from rapidly expanding genomic surveillance. Science 378, eabq5358 (2022).","journal-title":"Science"},{"key":"1516_CR52","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nprot.2017.066","volume":"12","author":"J Quick","year":"2017","unstructured":"Quick, J. et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat. Protoc. 12, 1261\u20131266 (2017).","journal-title":"Nat. Protoc."},{"key":"1516_CR53","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nature22401","volume":"546","author":"NR Faria","year":"2017","unstructured":"Faria, N. R. et al. Establishment and cryptic transmission of Zika virus in Brazil and the Americas. Nature 546, 406\u2013410 (2017).","journal-title":"Nature"},{"key":"1516_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature16996","volume":"530","author":"J Quick","year":"2016","unstructured":"Quick, J. et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 530, 228\u2013232 (2016).","journal-title":"Nature"},{"key":"1516_CR55","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/v12091020","volume":"12","author":"F Vairo","year":"2020","unstructured":"Vairo, F. et al. Chikungunya outbreak in the Republic of the Congo, 2019\u2014epidemiological, virological and entomological findings of a south-north multidisciplinary taskforce investigation. Viruses 12, 1020 (2020).","journal-title":"Viruses"},{"key":"1516_CR56","first-page":"e00583-","volume":"59","author":"C Smith","year":"2021","unstructured":"Smith, C. et al. Assessing nanopore sequencing for clinical diagnostics: a comparison of next-generation sequencing (NGS) methods for Mycobacterium tuberculosis. J. Clin. Microbiol. 59, e00583-20 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"1516_CR57","doi-asserted-by":"publisher","first-page":"191","DOI":"10.12688\/wellcomeopenres.15603.1","volume":"4","author":"M Hunt","year":"2019","unstructured":"Hunt, M. et al. Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with mykrobe [version 1; peer review: 2 approved, 1 approved with reservations]. Wellcome Open Res. 4, 191 (2019).","journal-title":"Wellcome Open Res."},{"key":"1516_CR58","doi-asserted-by":"crossref","unstructured":"Hall, M. B. et al. Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis. Lancet Microbe 4, e84\u2013e92 (2023).","DOI":"10.1016\/S2666-5247(22)00301-9"},{"key":"1516_CR59","doi-asserted-by":"crossref","unstructured":"Leggett, R. M. et al. Rapid MinION profiling of preterm microbiota and antimicrobial-resistant pathogens. Nat. Microbiol. 5, 430\u2013442 (2020).","DOI":"10.1038\/s41564-019-0626-z"},{"key":"1516_CR60","doi-asserted-by":"publisher","unstructured":"Greninger, A. L. et al. Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. Genome Med. https:\/\/doi.org\/10.1186\/s13073-015-0220-9 (2015).","DOI":"10.1186\/s13073-015-0220-9"},{"key":"1516_CR61","first-page":"mgen000490","volume":"7","author":"G Tegha","year":"2021","unstructured":"Tegha, G. et al. Genomic epidemiology of Escherichia coli isolates from a tertiary referral center in Lilongwe, Malawi. Microb. Genom. 7, mgen000490 (2021).","journal-title":"Microb. Genom."},{"key":"1516_CR62","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/jac\/dkw397","volume":"72","author":"K Schmidt","year":"2017","unstructured":"Schmidt, K. et al. Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing. J. Antimicrob. Chemother. 72, 104\u2013114 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"1516_CR63","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1038\/s41598-020-64616-x","volume":"10","author":"AM Taxt","year":"2020","unstructured":"Taxt, A. M., Avershina, E., Frye, S. A., Naseer, U. & Ahmad, R. Rapid identification of pathogens, antibiotic resistance genes and plasmids in blood cultures by nanopore sequencing. Sci. Rep. 10, 7622 (2020).","journal-title":"Sci. Rep."},{"key":"1516_CR64","doi-asserted-by":"crossref","unstructured":"Sereika, M. et al. Oxford Nanopore R10.4 long-read sequencing enables the generation of near-finished bacterial genomes from pure cultures and metagenomes without short-read or reference polishing. Nat. Methods 19, 823\u2013826 (2022).","DOI":"10.1038\/s41592-022-01539-7"},{"key":"1516_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-018-5094-y","volume":"19","author":"ND Sanderson","year":"2018","unstructured":"Sanderson, N. D. et al. Real-time analysis of nanopore-based metagenomic sequencing from infected orthopaedic devices. BMC Genomics 19, 1714 (2018).","journal-title":"BMC Genomics"},{"key":"1516_CR66","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1101\/gr.262865.120","volume":"30","author":"ND Sanderson","year":"2020","unstructured":"Sanderson, N. D. et al. High precision Neisseria gonorrhoeae variant and antimicrobial resistance calling from metagenomic Nanopore sequencing. Genome Res. 30, 1354\u20131363 (2020).","journal-title":"Genome Res."},{"key":"1516_CR67","doi-asserted-by":"publisher","unstructured":"Street, T. L. et al. Clinical metagenomic sequencing for species identification and antimicrobial resistance prediction in orthopedic device infection. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/jcm.02156-21 (2022).","DOI":"10.1128\/jcm.02156-21"},{"key":"1516_CR68","doi-asserted-by":"publisher","unstructured":"Xu, Y. et al. Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission, United Kingdom, 2018\/19 influenza season. Eurosurveillance https:\/\/doi.org\/10.2807\/1560-7917.ES.2021.26.27.2000004 (2021).","DOI":"10.2807\/1560-7917.ES.2021.26.27.2000004"},{"key":"1516_CR69","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13073-021-00991-y","volume":"13","author":"T Charalampous","year":"2021","unstructured":"Charalampous, T. et al. Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units. Genome Med. 13, 182 (2021).","journal-title":"Genome Med."},{"key":"1516_CR70","doi-asserted-by":"crossref","unstructured":"Sedlazeck, F. J. et al. Accurate detection of complex structural variations using single-molecule sequencing. Nat. Methods 15, 461\u2013468 (2018).","DOI":"10.1038\/s41592-018-0001-7"},{"key":"1516_CR71","doi-asserted-by":"publisher","unstructured":"Cretu Stancu, M. et al. Mapping and phasing of structural variation in patient genomes using nanopore sequencing. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-017-01343-4 (2017).","DOI":"10.1038\/s41467-017-01343-4"},{"key":"1516_CR72","unstructured":"The Power of Q20+ Chemistry (Oxford Nanopore Technologies, 2022)."},{"key":"1516_CR73","doi-asserted-by":"publisher","unstructured":"Runtuwene, L. R. et al. Nanopore sequencing of drug-resistance-associated genes in malaria parasites, Plasmodium falciparum. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-018-26334-3 (2018).","DOI":"10.1038\/s41598-018-26334-3"},{"key":"1516_CR74","doi-asserted-by":"publisher","unstructured":"Imai, K. et al. An innovative diagnostic technology for the codon mutation C580Y in kelch13 of Plasmodium falciparum with MinION nanopore sequencer. Malar. J. https:\/\/doi.org\/10.1186\/s12936-018-2362-x (2018).","DOI":"10.1186\/s12936-018-2362-x"},{"key":"1516_CR75","doi-asserted-by":"publisher","unstructured":"Razook, Z. et al. Real time, field-deployable whole genome sequencing of malaria parasites using nanopore technology. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.12.17.423341 (2020).","DOI":"10.1101\/2020.12.17.423341"},{"key":"1516_CR76","doi-asserted-by":"publisher","unstructured":"Cesare, M. et al. Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.02.06.527333 (2023).","DOI":"10.1101\/2023.02.06.527333"},{"key":"1516_CR77","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1111\/jcmm.12313","volume":"18","author":"O Friedrich","year":"2014","unstructured":"Friedrich, O., Reiling, S. J., Wunderlich, J. & Rohrbach, P. Assessment of Plasmodium falciparum PfMDR1 transport rates using Fluo-4. J. Cell. Mol. Med. 18, 1851\u20131862 (2014).","journal-title":"J. Cell. Mol. Med."},{"key":"1516_CR78","unstructured":"nanoporetech\/medaka (GiHub, 2021)."},{"key":"1516_CR79","doi-asserted-by":"publisher","unstructured":"Garrison, E. & Marth, G. Haplotype-based variant detection from short-read sequencing. Preprint at https:\/\/doi.org\/10.48550\/arXiv.1207.3907 (2012).","DOI":"10.48550\/arXiv.1207.3907"},{"key":"1516_CR80","unstructured":"MalariaGEN. Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples. Wellcome Open Res. 8, 22 (2023)."},{"key":"1516_CR81","doi-asserted-by":"publisher","unstructured":"Ajogbasile, F. V. et al. Molecular profiling of the artemisinin resistance Kelch 13 gene in Plasmodium falciparum from Nigeria. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0264548 (2022).","DOI":"10.1371\/journal.pone.0264548"},{"key":"1516_CR82","doi-asserted-by":"publisher","first-page":"e00802","DOI":"10.1128\/AAC.00802-19","volume":"63","author":"SA Matrevi","year":"2019","unstructured":"Matrevi, S. A. et al. Plasmodium falciparum kelch propeller polymorphisms in clinical isolates from Ghana from 2007 to 2016. Antimicrob. Agents Chemother. 63, e00802\u2013e00819 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1516_CR83","doi-asserted-by":"publisher","first-page":"e8603","DOI":"10.1002\/ece3.8603","volume":"12","author":"AR Vierstraete","year":"2022","unstructured":"Vierstraete, A. R. & Braeckman, B. P. Amplicon_sorter: a tool for reference-free amplicon sorting based on sequence similarity and for building consensus sequences. Ecol. Evol. 12, e8603 (2022).","journal-title":"Ecol. Evol."},{"key":"1516_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/aasopenres.12825.1","volume":"1","author":"J Abugri","year":"2018","unstructured":"Abugri, J. et al. Prevalence of chloroquine and antifolate drug resistance alleles in Plasmodium falciparum clinical isolates from three areas in Ghana. AAS Open Res. 1, 1 (2018).","journal-title":"AAS Open Res."},{"key":"1516_CR85","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1086\/655659","volume":"202","author":"MK Laufer","year":"2010","unstructured":"Laufer, M. K. et al. Return of chloroquine-susceptible falciparum malaria in malawi was a reexpansion of diverse susceptible parasites. J. Infect. Dis. 202, 801\u2013808 (2010).","journal-title":"J. Infect. Dis."},{"key":"1516_CR86","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijpara.2006.09.001","volume":"37","author":"GD Weedall","year":"2007","unstructured":"Weedall, G. D., Preston, B. M. J., Thomas, A. W., Sutherland, C. J. & Conway, D. J. Differential evidence of natural selection on two leading sporozoite stage malaria vaccine candidate antigens. Int. J. Parasitol. 37, 77\u201385 (2007).","journal-title":"Int. J. Parasitol."},{"key":"1516_CR87","doi-asserted-by":"publisher","first-page":"775","DOI":"10.4269\/ajtmh.2012.11-0478","volume":"86","author":"K Gandhi","year":"2012","unstructured":"Gandhi, K. et al. Next generation sequencing to detect variation in the Plasmodium falciparum circumsporozoite protein. Am. J. Trop. Med. Hyg. 86, 775\u2013781 (2012).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1516_CR88","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/infdis\/jis329","volume":"206","author":"JA Bailey","year":"2012","unstructured":"Bailey, J. A. et al. Use of massively parallel pyrosequencing to evaluate the diversity of and selection on Plasmodium falciparum csp T-cell epitopes in Lilongwe, Malawi. J. Infect. Dis. 206, 580\u2013587 (2012).","journal-title":"J. Infect. Dis."},{"key":"1516_CR89","doi-asserted-by":"publisher","first-page":"e62427","DOI":"10.1371\/journal.pone.0062427","volume":"8","author":"NR Aragam","year":"2013","unstructured":"Aragam, N. R. et al. Diversity of T cell epitopes in Plasmodium falciparum circumsporozoite protein likely due to protein\u2013protein interactions. PLoS ONE 8, e62427 (2013).","journal-title":"PLoS ONE"},{"key":"1516_CR90","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","volume":"373","author":"DE Neafsey","year":"2015","unstructured":"Neafsey, D. E. et al. Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine. N. Engl. J. Med. 373, 2025\u20132037 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1516_CR91","doi-asserted-by":"publisher","unstructured":"Pringle, J. C. et al. RTS,S\/AS01 malaria vaccine mismatch observed among Plasmodium falciparum isolates from southern and central Africa and globally. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-018-24585-8 (2018).","DOI":"10.1038\/s41598-018-24585-8"},{"key":"1516_CR92","doi-asserted-by":"publisher","unstructured":"Naung, M. T. et al. Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens. PLoS Comput. Biol. https:\/\/doi.org\/10.1371\/journal.pcbi.1009801 (2022).","DOI":"10.1371\/journal.pcbi.1009801"},{"key":"1516_CR93","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1073\/pnas.85.4.1199","volume":"85","author":"MF Good","year":"1988","unstructured":"Good, M. F. et al. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc. Natl Acad. Sci. USA 85, 1199\u20131203 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1516_CR94","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4269\/ajtmh.2003.68.97","volume":"68","author":"A Alloueche","year":"2003","unstructured":"Alloueche, A. et al. Protective efficacy of the RTS,S\/AS02 Plasmodium falciparum malaria vaccine is not strain specific. Am. J. Trop. Med. Hyg. 68, 97\u2013101 (2003).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1516_CR95","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1371\/journal.pctr.0010005","volume":"1","author":"S Enosse","year":"2006","unstructured":"Enosse, S. et al. RTS,S\/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin. Trials 1, e5 (2006).","journal-title":"PLoS Clin. Trials"},{"key":"1516_CR96","doi-asserted-by":"publisher","unstructured":"Early A. M. et al. Detection of low-density Plasmodium falciparum infections using amplicon deep sequencing. Malar. J. https:\/\/doi.org\/10.1186\/s12936-019-2856-1 (2019).","DOI":"10.1186\/s12936-019-2856-1"},{"key":"1516_CR97","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12936-017-1886-9","volume":"16","author":"JM Ngondi","year":"2017","unstructured":"Ngondi, J. M. et al. Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling and next-generation sequencing. Malar. J. 16, 236 (2017).","journal-title":"Malar. J."},{"key":"1516_CR98","doi-asserted-by":"publisher","first-page":"e02474","DOI":"10.1128\/AAC.02474-17","volume":"62","author":"E Talundzic","year":"2018","unstructured":"Talundzic, E. et al. Next-generation sequencing and bioinformatics protocol for malaria drug resistance marker surveillance. Antimicrob. Agents Chemother. 62, e02474-17 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1516_CR99","doi-asserted-by":"publisher","unstructured":"L\u2019Episcopia, M. et al. Targeted deep amplicon sequencing of kelch 13 and cytochrome b in Plasmodium falciparum isolates from an endemic African country using the Malaria Resistance Surveillance (MaRS) protocol. Parasit. Vectors https:\/\/doi.org\/10.1186\/s13071-020-4005-7 (2020).","DOI":"10.1186\/s13071-020-4005-7"},{"key":"1516_CR100","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/s41598-017-02724-x","volume":"7","author":"S Nag","year":"2017","unstructured":"Nag, S. et al. High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology. Sci. Rep. 7, 2398 (2017).","journal-title":"Sci. Rep."},{"key":"1516_CR101","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1128\/JCM.00235-16","volume":"54","author":"PN Rao","year":"2016","unstructured":"Rao, P. N. et al. A method for amplicon deep sequencing of drug resistance genes in Plasmodium falciparum clinical isolates from India. J. Clin. Microbiol. 54, 1500\u20131511 (2016).","journal-title":"J. Clin. Microbiol."},{"key":"1516_CR102","doi-asserted-by":"publisher","unstructured":"L\u2019Episcopia, M. et al. Targeted deep amplicon sequencing of antimalarial resistance markers in Plasmodium falciparum isolates from Cameroon. Int. J. Infect. Dis. https:\/\/doi.org\/10.1016\/j.ijid.2021.04.081 (2021).","DOI":"10.1016\/j.ijid.2021.04.081"},{"key":"1516_CR103","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1111\/1755-0998.13622","volume":"22","author":"E LaVerriere","year":"2022","unstructured":"LaVerriere, E. et al. Design and implementation of multiplexed amplicon sequencing panels to serve genomic epidemiology of infectious disease: a malaria case study. Mol. Ecol. Resour. 22, 2285\u20132303 (2022).","journal-title":"Mol. Ecol. Resour."},{"key":"1516_CR104","doi-asserted-by":"publisher","unstructured":"Gaye, A. et al. Amplicon deep sequencing of kelch13 in Plasmodium falciparum isolates from Senegal. Malar. J. https:\/\/doi.org\/10.1186\/s12936-020-03193-w (2020).","DOI":"10.1186\/s12936-020-03193-w"},{"key":"1516_CR105","doi-asserted-by":"crossref","unstructured":"Kattenberg, J. H. et al. Malaria molecular surveillance in the Peruvian Amazon with a novel highly multiplexed Plasmodium falciparum ampliseq assay. Microbiol. Spectr. 11, e0096022 (2023).","DOI":"10.1128\/spectrum.00960-22"},{"key":"1516_CR106","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/infdis\/jiac144","volume":"226","author":"K Wamae","year":"2022","unstructured":"Wamae, K. et al. Amplicon sequencing as a potential surveillance tool for complexity of infection and drug resistance markers in Plasmodium falciparum asymptomatic infections. J. Infect. Dis. 226, 920\u2013927 (2022).","journal-title":"J. Infect. Dis."},{"key":"1516_CR107","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/infdis\/jiaa527","volume":"225","author":"SK Tessema","year":"2022","unstructured":"Tessema, S. K. et al. Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome. J. Infect. Dis. 225, 1227\u20131237 (2022).","journal-title":"J. Infect. Dis."},{"key":"1516_CR108","doi-asserted-by":"publisher","first-page":"e063456","DOI":"10.1136\/bmjopen-2022-063456","volume":"12","author":"A Mayor","year":"2022","unstructured":"Mayor, A. et al. Prospective surveillance study to detect antimalarial drug resistance, gene deletions of diagnostic relevance and genetic diversity of Plasmodium falciparum in Mozambique: protocol. BMJ Open 12, e063456 (2022).","journal-title":"BMJ Open"},{"key":"1516_CR109","doi-asserted-by":"crossref","unstructured":"Ross, L. S. et al. Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine. Nat. Commun. 9, 3314 (2018).","DOI":"10.1038\/s41467-018-05652-0"},{"key":"1516_CR110","unstructured":"World Health Organization. WHO Guiding Principles for Pathogen Genome Data Sharing (WHO, 2022)."},{"key":"1516_CR111","doi-asserted-by":"publisher","first-page":"981432","DOI":"10.3389\/fcimb.2022.981432","volume":"12","author":"J Hoshizaki","year":"2022","unstructured":"Hoshizaki, J., Jagoe, H. & Lee, M. C. S. Efficient generation of mNeonGreen Plasmodium falciparum reporter lines enables quantitative fitness analysis. Front. Cell. Infect. Microbiol. 12, 981432 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1516_CR112","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","volume":"23","author":"T Koressaar","year":"2007","unstructured":"Koressaar, T. & Remm, M. Enhancements and modifications of primer design program Primer3. Bioinformatics 23, 1289\u20131291 (2007).","journal-title":"Bioinformatics"},{"key":"1516_CR113","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser, A. et al. Primer3-new capabilities and interfaces. Nucleic Acids Res. 40, e115 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1516_CR114","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/bioinformatics\/bty036","volume":"34","author":"T K\u00f5ressaar","year":"2018","unstructured":"K\u00f5ressaar, T. et al. Primer3-masker: integrating masking of template sequence with primer design software. Bioinformatics 34, 1937\u20131938 (2018).","journal-title":"Bioinformatics"},{"key":"1516_CR115","doi-asserted-by":"publisher","first-page":"52","DOI":"10.12688\/wellcomeopenres.14571.1","volume":"3","author":"TD Otto","year":"2018","unstructured":"Otto, T. D. et al. Long read assemblies of geographically dispersed Plasmodium falciparum isolates reveal highly structured subtelomeres [version 1; referees: 3 approved]. Wellcome Open Res. 3, 52 (2018).","journal-title":"Wellcome Open Res."},{"key":"1516_CR116","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094\u20133100 (2018).","journal-title":"Bioinformatics"},{"key":"1516_CR117","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"1516_CR118","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"1516_CR119","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genome viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-023-01516-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-023-01516-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-023-01516-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T13:07:01Z","timestamp":1701263221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-023-01516-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":119,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1516"],"URL":"https:\/\/doi.org\/10.1038\/s41564-023-01516-6","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"23 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}